AUA-recommended Antibiotic Prophylaxis for Primary Penile Implantation Results in a Higher, Not Lower, Risk for Postoperative Infection: A Multicenter Analysis.


Journal

The Journal of urology
ISSN: 1527-3792
Titre abrégé: J Urol
Pays: United States
ID NLM: 0376374

Informations de publication

Date de publication:
02 2023
Historique:
pubmed: 17 11 2022
medline: 11 1 2023
entrez: 16 11 2022
Statut: ppublish

Résumé

Our aim was to determine if the AUA-recommended prophylaxis (vancomycin + gentamicin alone) for primary inflatable penile prosthesis surgery is associated with a higher infection risk than nonstandard regimens. We performed a multicenter, retrospective study of patients undergoing primary inflatable penile prosthesis surgery. Patients were divided into those receiving vancomycin + gentamicin alone and those receiving any other regimen. A Cox proportional-hazards model was constructed adjusted for major predictors. A subgroup analysis to identify the appropriate dosage of gentamicin was also performed. A total of 4,161 patients underwent primary inflatable penile prosthesis placement (2,411 received vancomycin + gentamicin alone and 1,750 received other regimens). The infection rate was similar between groups, 1% vs 1.2% for standard vs nonstandard prophylaxis. In the multivariable analysis, vancomycin + gentamicin (HR: 2.7, 95% CI: 1.4 to 5.4, Vancomycin + gentamicin alone for antibiotic prophylaxis for primary inflatable penile prosthesis surgery is associated with a higher infection risk than nonstandard antibiotic regimens while antifungal use is associated with lower infection risk. A critical review of the recommended antimicrobial prophylactic regimens is needed. Prospective research is needed to further elucidate best practices in inflatable penile prosthesis antimicrobial prophylaxis.

Identifiants

pubmed: 36383789
doi: 10.1097/JU.0000000000003071
doi:

Substances chimiques

Vancomycin 6Q205EH1VU
Gentamicins 0

Types de publication

Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

399-409

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn

Auteurs

David W Barham (DW)

Department of Urology, University of California, Irvine, Orange, California.

Nikolaos Pyrgidis (N)

Department of Urology, 'Martha-Maria' Hospital Nuremberg, Nuremberg, Germany.

Martin S Gross (MS)

Section of Urology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.

Muhammed Hammad (M)

Department of Urology, University of California, Irvine, Orange, California.

Daniel Swerdloff (D)

Department of Urology/Urologic Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

Jake Miller (J)

Department of Urology, University of California, Irvine, Orange, California.

Abdullah Alkhayal (A)

Division of Urology, Department of Surgery, King Saud bin Abdulaziz University for Health Science, Riyadh, Saudi Arabia.

Khalid A Alrabeeah (KA)

Division of Urology, Department of Surgery, King Saud bin Abdulaziz University for Health Science, Riyadh, Saudi Arabia.

Robert Andrianne (R)

Service d'urologie, Centre Hospitalier Universitaire de Liege, Liege, Belgium.

Arthur L Burnett (AL)

Department of Urology, Johns Hopkins University, Baltimore, Maryland.

Kelli Gross (K)

Division of Urology, Department of Surgery, University of Utah, Salt Lake City, Utah.

Georgios Hatzichristodoulou (G)

Department of Urology, 'Martha-Maria' Hospital Nuremberg, Nuremberg, Germany.

James M Hotaling (JM)

Division of Urology, Department of Surgery, University of Utah, Salt Lake City, Utah.

Tung-Chin Hsieh (TC)

Department of Urology, University of California, San Diego, La Jolla, California.

Adam Jones (A)

Manchester Andrology Centre, Manchester University NHS Foundation Trust, Manchester, UK.

James M Jones (JM)

Section of Urology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.

Aaron Lentz (A)

Department of Urology, Duke University, Durham, North Carolina.

Jason Levy (J)

Department of Urology, Johns Hopkins University, Baltimore, Maryland.

Vaibhav Modgil (V)

Manchester Andrology Centre, Manchester University NHS Foundation Trust, Manchester, UK.

Daniar Osmonov (D)

Department of Urology, University Hospital Schleswig Holstein, Kiel, Germany.

Sung Hun Park (SH)

Sewum Prosthetic Urology Center of Excellence, Seoul, South Korea.

Ian Pearce (I)

Manchester Andrology Centre, Manchester University NHS Foundation Trust, Manchester, UK.

Paul Perito (P)

Perito Urology, Coral Gables, Florida.

Hossein Sadeghi-Nejad (H)

Division of Urology, Rutgers New Jersey Medical School, Newark, New Jersey.

Maxime Sempels (M)

Service d'urologie, Centre Hospitalier Universitaire de Liege, Liege, Belgium.

Alfredo Suarez-Sarmiento (A)

Perito Urology, Coral Gables, Florida.

Jay Simhan (J)

Department of Urology/Urologic Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

Koenraad van Renterghem (K)

Department of Urology, Jessa Hospital, Hasselt, Belgium.

J Nicholas Warner (JN)

Department of Urology, Mayo Clinic, Rochester, Minnesota.

Matthew Ziegelmann (M)

Department of Urology, Mayo Clinic, Rochester, Minnesota.

Faysal A Yafi (FA)

Department of Urology, University of California, Irvine, Orange, California.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH